Karl-Heinz Klempnauer
5PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 17, 2022
A New Naphthopyran Derivative Combines c-Myb Inhibition, Microtubule-Targeting Effects, and Antiangiogenic Properties.Leonhard H F Köhler, Sebastian Reich, Maria Yusenko
|May 07, 2021
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.Maria V Yusenko, Amke Trentmann, Debora A Casolari
|Mar 31, 2021
The CDC37-HSP90 chaperone complex co-translationally degrades the nascent kinase-dead mutant of HIPK2.Jan Paul Müller, Karl-Heinz Klempnauer
|Sep 26, 2020
Intramolecular interaction of B-MYB is regulated through Ser-577 phosphorylation.Eugen Werwein, Abhiruchi Biyanee, Karl-Heinz Klempnauer
|Feb 03, 2018
The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.Anna Coulibaly, Astrid Haas, Simone Steinmann
Pageof 1
